Pfizer announced Wednesday morning that it would seek approval for its COVID vaccine within days after a final analysis showed better results than those reported last week. NBC News reports: “The U.S. pharma giant and its German partner said their Phase 3 trial was now complete, and that it found the vaccine was 95 percent … Continue reading Pfizer to Seek Approval for COVID Vaccine Within Days After Final Analysis Shows it’s 95 Percent Effective with No Serious Side Effects